Ramen spectroscopy

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has opened a new center at its facility in Tewksbury, Mass., it announced today.

The device, named the Verisante Aura, uses Raman spectroscopy to measure levels of various biomarkers – including proteins, nucleic acids, and metabolites – in skin lesions. In initial clinical trials it distinguished between benign and malignant lesions with 100-percent sensitivity and 70-percent specificity.

ICAP Ocean Tomo has conducted due diligence to rate the strength of the patents and is marketing the portfolio to various healthcare and other companies that might be interested in commercializing the technology, which can be used to monitor a patient's blood glucose or substances in the brain and cerebrospinal fluid.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.